Synthetic Biology
Semi-Synthetic Artemisinin - The Beginning of the SynthBio Revolution? - An Interview with Jay Keasling
November 02 by Gerald ClarkeArtemisinin is a front line anti-malarial drug which was derived from the sweet wormwood plant. ‘Growing on trees’ however, isn’t all it’s cracked up to be and the supply cou...
Synthetic Biology in the Pharma Industry- An Interview with Professor James Collins
August 08 by Gerald ClarkeAs part of our Future Pharma series, Pharma IQ is examining the promise held by synthetic biology. Our editor spoke to Professor James Collins, Professor of Biomedical Engineering at Boston Universi...
Synthetic Biology: New Tools, New Approaches, New Thinking- Interview with Professor Paul Freemont
August 08 by Gerald ClarkeAs part of our Future Pharma series, Pharma IQ is examining the promise held by synthetic biology. Our editor spoke to Professor Paul Freemont Chair in Protein Crystallography and Co-Founder and Co-...
Mirror Life: Changing the Pharma Landscape with Synthetic Biology- An Interview with Professor George Church
April 24 by George M. ChurchGerald Clarke: I’m Gerald Clarke, Editor at Pharma IQ. Today I’m joined by Professor George Church, Professor of Genetic...
Synthetic Biology in the Pharma Industry- An Interview with Professor James Collins
April 24 by James CollinsGerald Clarke: Hello, I’m Gerald Clarke editor at Pharma IQ, www.pharma-iq.com. Today I’m joined by Professor James Collins, profes...
Synthetic Biology: New Tools, New Approaches, New Thinking- Interview with Professor Paul Freemont
April 24 by Paul FreemontGerald Clarke: Hello, I’m Gerald Clarke, editor at PharmaIQ. Today I’m joined by Professor Paul Freemont, Chair in Protein Cry...